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It could be a ‘Golden Goose’: a qualitative
study of views in primary care on an
emergency admission risk prediction tool
prior to implementation
Alison Porter1*, Mark Rhys Kingston1, Bridie Angela Evans1, Hayley Hutchings1, Shirley Whitman2
and Helen Snooks1
Abstract
Background: Rising demand for health care has prompted interest in new technologies to support a shift of care
from hospital to community and primary care, which may require clinicians to undertake new working practices. A
predictive risk stratification tool (Prism) was developed for use in primary care to estimate patients’ risk of an
emergency hospital admission. As part of an evaluation of Prism, we aimed to understand what might be needed
to bring Prism into effective use by exploring clinicians and practice managers’ attitudes and expectations about
using it. We were informed by Normalisation Process Theory (NPT) which examines the work needed to bring an
innovation into use.
Methods: We conducted 4 focus groups and 10 interviews with a total of 43 primary care doctors and colleagues
from 32 general practices. All were recorded and transcribed. Analysis focussed in particular on the construct of
‘coherence’ within NPT, which examines how people understand an innovation and its purpose.
Results: Respondents were in agreement that Prism was a technological formalisation of existing practice, and that
it would function as a support to clinical judgment, rather than replacing it. There was broad consensus about the
role it might have in delivering new models of care based on active management, but there were doubts about
the scope for making a difference to some patients and about whether Prism could identify at-risk patients not
already known to the clinical team. Respondents did not expect using the tool to be onerous, but were concerned
about the work which might follow in delivering care. Any potential value would not be of the tool in isolation, but
would depend on the availability of support services.
Conclusions: Policy imperatives and the pressure of rising demand meant respondents were open to trying out
Prism, despite underlying uncertainty about what difference it could make.
Trial registration: Controlled Clinical Trials no. ISRCTN55538212.
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Background
Rising demand for health care, particularly from people
living with long term conditions, is prompting service
providers and policy makers to turn to new technologies
in order to improve efficiency and effectiveness. Clinical
risk prediction models use demographic information,
diagnoses, and service use data to stratify a population’s
risk of having or developing a specified disease, or ex-
periencing an outcome such as emergency admission to
hospital [1, 2]. In combination with a software platform,
the models provide clinical risk prediction tools [3],
whose two functions in supporting health care are case
finding for improved clinical management, and resource
allocation through budgeting or service planning [4]. In
terms of case finding, such tools are seen as potentially
more accurate and consistent than clinical opinion in
identifying patients at risk of unscheduled hospital ad-
mission [5]. In recent years, contractual mechanisms in
all four nations of the UK have incentivised risk profiling
and stratification as part of a proactive model of care for
patients at risk of emergency admission [6, 7]. The fund-
ing commitment is considerable: £160 million per year
in England alone [6].
Though a systematic review identified 27 validated risk
models for emergency hospital admissions in use inter-
nationally [8], their clinical and cost effectiveness have
not been demonstrated and practical aspects of adoption
and use in general practice are poorly understood [9]. A
range of risk prediction tools—including the Combined
Model [10] developed for NHS England, and QAdmis-
sions [11]—are intended to produce stratified lists of pa-
tients, but there is some variation in the underlying
modelling (for example, whether or not secondary care
data is used alongside primary care data). Prism [12] is a
tool developed specifically for NHS Wales, using a 37-
variable model based on Welsh data sets, and updated
monthly with data from GP practices, and designed to
reflect the particular service configuration of the Welsh
NHS and the service needs of the Welsh population. We
are currently evaluating Prism in general practice in
Wales [13], including examining how Prism is being im-
plemented into practice.
Implementation into health care of new technology such
as risk prediction tools can be slow and difficult [14, 15].
There is an increasing acknowledgement of the complex-
ities of the process of bringing new technology into rou-
tine use: what is implemented is a package of behaviour
change, not just a piece of equipment or protocol [16]; it is
a process over time [16, 17] and it involves a complex so-
cial system, in which multiple parties are involved [17–19],
some of which may be resistant [20].
Normalisation Process Theory (NPT) [21] is increas-
ingly being used as a conceptual framework to examine
and explain implementation of innovations in health
care [22]. NPT emphasises the nature of implementation
as a process which entails sustained work by the parties
involved, and suggests that four constructs help us under-
stand how innovation is brought into normal everyday
practice: how people understand the innovation and its
purpose (coherence); what decisions are taken about using
it, based on perceived advantages (cognitive participation);
what people do to bring the innovation into everyday use
(collective action); how an innovation is reviewed, modi-
fied or abandoned (reflexive monitoring) [23].
Our qualitative study aims to understand what might
be needed to bring Prism into effective use by exploring
clinicians’ and practice managers’ attitudes and expecta-
tions about using it. We used NPT to inform our ana-
lysis, focussing in particular on the first construct,
coherence. Our study contributes new understanding of
the ambiguities of the real-world expectations of primary
care practitioners when presented with an opportunity
to adopt a technology into practice. It will both help to
inform effective implementation, and to bring new in-
sights to process evaluation of interventions which are
being trialled to assess their impact.
Methods
Setting and intervention
We undertook this qualitative study of the process of
implementing the Prism risk prediction tool in primary
care as part of a progressive cluster randomised trial of
the tool, in line with recent MRC recommendations on
process evaluation [24]. PRISMATIC (ISRCTN55538212)
(Prism Risk Stratification Model: A Trial in Chronic con-
ditions management) aims to estimate Prism’s effects on
delivery of care, patient satisfaction, quality of life and re-
sources used [13]. PRISMATIC is under way in one Welsh
health board area where 32 practices volunteered to par-
ticipate. The intervention consisted of Prism software, in-
stalled on the practice computer system and providing a
range of searchable graphical and numerical presentations
of risk information at individual or practice level, automat-
ically updated monthly from routine data. To support this,
practices were also provided with a training session of ap-
proximately 1 h, delivered in the practice; clinical support
through two locally appointed ‘GP champions’; a tele-
phone ‘help desk’ at the NHS Wales Informatics Service
(NWIS), during working hours; and a user-friendly hand-
book of guidance on using Prism. Participating practices
received a payment of £1250 to cover costs associated
with taking part in the trial.
Qualitative data collection took place between October
2012 and April 2013, after the Prism software was installed
on the practice computer system, but before Prism was ac-
tivated for use or training provided. During the course of
the data collection, NHS Wales announced that the con-
tract with primary care providers for 2013–14 would
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include an additional payment for active care management
of at least 0.5 % of the practice list predicted to be at high
risk of hospital admission [7]. Some data collection took
place before this announcement, and some after it.
Participants
We invited each GP who had been nominated as lead
for Prism in participating practices to attend one of four
focus groups, along with other staff members (such as
practice manager or nurse) if desired. 33 respondents
attended focus groups—Group A (5 GPs; 4 practice man-
agers; 1 nurse), Group B (4:3:1), Group C (7:1:0), Group D
(5:2:0). We also interviewed 10 GPs who were unable to
attend, by telephone (n = 8) or in person (n = 2), giving a
total of 43 participants from across all 32 practices. Partic-
ipants represented a mix of urban, rural and semi-rural
practices. 21 were female. Mean number of years of ex-
perience in their role was 14 (range: 3 to 28).
Data collection
We devised a topic guide (piloted before use) for focus
groups and interviews, covering knowledge of existing
predictive risk tools; approaches currently used to iden-
tify patients at risk of hospitalisation; motivations for
participating in the PRISMATIC trial; expectations of
Prism use and impact; and any concerns. During the
course of the focus group/interview, we presented a sum-
mary of the Prism tool with screenshots to enable respon-
dents to understand and visualise how they might use it in
practice. Focus groups, conducted by BAE or AP sup-
ported by MK, lasted 65–90 min. Interviews, conducted
by the same researchers, lasted 28–40 min. All were re-
corded, with consent, and fully transcribed, except for one
interview where detailed notes were taken.
Analysis
We used May and Finch’s [21] NPT to frame our ana-
lysis. We focused on the first of their constructs, coher-
ence, to examine what understanding participating GPs
and primary care colleagues had of Prism before they
started to use the innovation. In line with NPT, we con-
sidered coherence in terms of various tasks which
people (individually or collectively) may undertake in re-
lation to an innovation:
1) differentiating it from other practices;
2) agreeing its purpose;
3) understanding how they might use it;
4) identifying its potential value.
NPT suggests that each of these tasks is shaped by fac-
tors that promote or inhibit the extent to which partici-
pants look on a new practice as meaningful.
In line with the method outlined by Bradley et al., our
analysis integrated inductive and deductive approaches
[25]. We developed an initial coding frame for analysis,
informed by NPT and by the major concepts identified
by BAE, AP, MK and service user SW during an initial
review of transcripts, and revised and refined this frame
during analysis. We used NVIVO 9 software to organise
and manage data, to code into groups and connect data
into meaningful themes. AP and MK led coding, com-
paring results and meeting with all authors to confirm
consistency and resolve discrepancies through discussion
and comparison with raw data. To strengthen credibility,
we presented findings to three GPs associated with the
study who agreed they were ‘recognisable’ and seemed
to ‘fit’ with their experience [26].
Ethics
The PRISMATIC trial, including this qualitative compo-
nent, received approval from the National Research Ethics
Service for Wales (10/MRE09/25). We gained informed
consent from all participants before data collection. We
followed recommended ethical standards for conducting
this study and storing all data [27].
Results
Defining and differentiating Prism from current practice
Respondents discussed what they understood Prism to
be, and how it offered something distinct from existing
practice. The consensus was that Prism was a potentially
useful technological contribution to case-finding as part
of the current trend in general practice towards identify-
ing individuals for case management, through a more
proactive, rather than reactive, model of care:
We want a systematic way rather than just seeing
people opportunistically because they are ill, we want
to get there before they’re ill and on the point of going
into hospital. We want to do it in a more orderly
manner. [GP 30, Group D]
The Prism tool was not seen as something entirely
new. Many respondents made comparison between the
principles and process of Prism and condition-specific
risk prediction tools with which they were already famil-
iar, such as the Wells score (estimating the probability of
deep vein thrombosis or pulmonary embolism) and Fra-
mingham score (cardiovascular risk).
Views varied on whether the Prism technology would
be more accurate than the GPs’ own judgement. While
they strongly defended their clinical expertise and patient
knowledge, some respondents recognised that a formal
and systematic process could complement current clinical
practice, including the ‘intuitive risk assessments’ [GP 30,
Group D] they routinely carried out. Though colleagues
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such as practice managers were seen as having a role in
accessing the data, most respondents suggested that risk
scores needed to be interpreted by GPs, informed by their
knowledge of individual patient situations. As a minimum,
information from the risk prediction technology would
confirm their opinions; at best, it could enhance clinicians’
role in case finding, supplementing their clinical and local
expertise by centralising information, giving reminders
and highlighting the unusual. It was also observed that the
tool could provide a technological rationalisation or justi-
fication for clinical decision-making:
We can always refer back to that tool that “this is the
scoring system, that was the reason I admitted this
patient or they did not need admission”. [GP 25,
Group B]
It was also suggested by one respondent that the
process of implementing the tool could in itself be a
spur to change in practice:
We have been thinking for a while about looking more
in depth at some of the—certain individuals. And I
think this might give us the impetus to actually carry
that through. [GP 15, Interview]
Agreeing a purpose for Prism
Many respondents described the potential of Prism in
supporting policy imperatives to prevent admissions—‘-
something that we’re very much being pressured to do’
[GP 16, IV]—while at the same time enabling practices
to meet contractual and reporting responsibilities. Prism
was seen as being able to help with the identification of
patients at high-risk of emergency admission, so that
home based nursing care could be provided through a
community support team:
That’s how I would go about it, you see, identifying the
patients that may have a problem, put in place, or
mobilise forces that might be able to go in, and help a
little bit—you know, if somebody has a chest infection
and they’re having difficulty in breathing, they’re in
need of—intravenous antibiotics, the [community
support] team can do that at home—she doesn’t have
to go in. [GP 9, Interview]
However, a range of reservations were expressed by
many of the respondents. One was that, while the tool
might be able to identify patients at risk, its purpose
would be limited in that it would not necessarily be tell-
ing practice staff anything they did not already know:
I suppose, one of the overwhelming senses, was that if
somebody were to give us a list of our top 100 patients,
we’d say, “Well, yeah, you know, we already know
about them.” ....We felt that the chance of this
churning out unexpected patients was probably pretty
low. [GP 15, Interview]
The second reservation was that, though patients may
be identified as high risk, it was not necessarily possible
to do anything to mitigate that risk:
The idea is that you can predict who they are and you
can do something about it, so they don’t need to be
going into hospital. And that sort of assumes lots of
things, really. I mean, it assumes first of all that you
can predict it, but secondly it presumes that some of
these things are modifiable. [GP 15, Interview]
There were, among a minority of respondents, anxie-
ties about implications in terms of performance manage-
ment, if practices were to identify needs but then fail to
respond to them:
So, if your patient has a certain level of risk, in the top
5 %…and you haven’t [been able] to get them lower…
that’s my worry, because it’ll be like a stick to beat
you. [GP 12, Group C]
Though the function of Prism was generally identified
as being individual case finding, a minority of respon-
dents recognised a potential role in service planning.
They saw Prism as an opportunity to demonstrate how
to improve community services by highlighting patients’
unmet needs:
If this helps us define and gives evidence to what we
need, that’s where I see it coming from. [GP 13, Group
C]
In interviews and focus groups, most respondents
reflected on Prism from an individual perspective, rather
than reporting any collective viewpoint in their practice.
However, a minority of respondents did report on dis-
cussions with colleagues about Prism, with GPs saying
that they had persuaded partners, and some practice
managers that they had convinced GPs, to take the op-
portunity to try the technology.
Understanding how they might use Prism
Respondents described the work that they thought
would be required of them, or their practice colleagues,
to bring Prism into use. From the majority, there was a
sense of open-mindedness about trying it, with some un-
certainty about what work it would actually involve. One
GP speculated that in technical terms it would be rela-
tively straightforward to install and use:
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If it looks like that on the webpage, then that’s very
usable, isn’t it. It’s clicking and it’s very organised and
the figures are there nice and neatly and you can
scroll up and down over a cup of coffee. [GP 19,
Group D]
A minority of respondents described plans for working
together with other practice staff to bring Prism into
use:
We’ll involve the whole practice. We’ll involve the
nurses—the clinical side, isn’t it? And we’ll have a look
at it in clinical meetings, which we have in any case,
and we’ll go from there, I think. [GP 1, Interview]
It wouldn’t be everybody using it, but I think as long
as we’ve got a doctor onboard…I’m there, and then it’s
the nurse—a small group…Sometimes if you get too
many people involved, nothing gets done. [Practice
Manager 7, Group A]
I think obviously a meeting first of all…to lead us in
the right direction…[work with the patient] will come
my way. [Practice Nurse, Group B]
However, more often there was a sense that there was
no coherent interest in Prism across the practice, with
some individuals being more inclined to use it than
others. There was an acknowledgement that it might not
be easy to persuade colleagues to use Prism, because it
could be seen as bringing additional work, in a context
where clinicians already felt fully stretched:
If we say, “Well, we’re gonna do this, but it might
make X hours extra work,” [my partners] will say to
me, “Well, where’s that X hours gonna come from?”.
[GP 9, Interview]
We struggle at the moment anyway—everybody’s the
same with time, with clinics, scripts, mail—everything.
After all of this there’s not much time to put in.
[Practice Manager 4, Group C].
As well as concerns about the work involved in imple-
menting Prism (learning how to use it, logging on, run-
ning searches) there were some concerns about the
additional work which might come from needing to ac-
tively case manage any patients identified:
If you are presented with a list of patients who are
deemed to be high risk and there may be people that
you haven’t had contact with, that obviously is gonna
generate work because you can’t really ignore the fact
that they’re deemed at risk and you’d then have to
visit or contact them.[GP 25, Group C]
Especially if this tool identified patients that are
unknown to us, then you’ve gotta go digging…Because
we know—we all know Dai down the road, with
COPD, who’s back and forth all the time, because he’s
in the surgery all the time. But, then, Mr Thomas
down here, who we said, “Well, who the hell is he?”.
[Practice Manager 31, Group A]
Identifying potential value for Prism
GPs and practice staff showed a willingness and open-
mindedness about trying the Prism risk prediction tool.
Some were curious, keen to find out about new technol-
ogy or to avoid missing extra resources or information
which could improve their patient care. Most saw an op-
portunity to help their general practice by supplement-
ing their access to data and supporting the move
towards proactive health care. But underlying the appar-
ent curiosity, there was an urgent and anxious search for
ways to change working practices and pressures, to
move away from current practices which were seen as
unsustainable, a case of ‘trying to keep our head above
water.’ [GP 18, Group B]
Despite concerns that the risk prediction technology
could add to their workload, many felt they had to try it
because the alternative was not an option for them.
I’ll give it a go, see if it does work, if it doesn’t at least
we tried, otherwise we just stay in the status quo,
which we can’t stay in as the current health service is
being funded. [GP 20, Group C]
One GP summed up the mixture of curiosity, uncer-
tainty, and desire for change which prompted them to
sign up for the technology:
So part of me coming [to the focus group] is to see
what we can do with it…we all do it [identifying
people at risk] on a sort of informal basis. We
recognise who’s ill and who’s the really worrying
patients…if you can use that [Prism], then it has a
benefit but what that is, is a Golden Goose so to speak.
[GP 6, Group D]
Respondents’ willingness to use Prism was in the face
of real anxieties about its role in improving care.
There was consensus among respondents that Prism’s
value was not as a tool in isolation, but as a way of
identifying people for referral to community services
or resources. If these were not available, then the
scope for Prism to make a difference would be lim-
ited. Respondents felt challenged by limited capacity,
within the practice and among community staff, to
respond to identified needs:
We have to have a system in place, where there is an
alternative…if there’s no alternative, then all of our
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GPs, all we’re gonna do is just say “admit, admit,
admit”. [GP 11, Interview]
Respondents pointed out gaps in the provision of com-
munity services, the heavy workloads of district nurses,
and the lack of integration between social and voluntary
services. Potential negative impacts of Prism were also
noted. Respondents expressed anxieties about raising pa-
tient expectations inappropriately:
You know, there’s nothing worse than saying to
somebody, “Well, actually, you need this, but we can’t
give it to you.” [GP 26, Interview]
Respondents were also concerned about the potential
impact on staff of identifying needs which they were
then unable to meet:
And it may identify work—a workload—or it may
identify needs, that we may feel unable to address.
That can be demoralising, can’t it?…And frustrating.
[GP 9, Interview]
Despite deep anxieties about extra work and lack of
resources, and uncertainties about potential benefits,
there was a common sense among respondents that they
had to take up an opportunity which had the potential
to be beneficial:
GPs will generally use anything that they feel is of
benefit to their patients. I think the difficulty I would
have is not really knowing if it is gonna be of benefit.
I’m quite happy to give it a go. [GP 21, Group C]
Discussion
New health care technologies are promoted as a way to
improve the quality of patient care and effectiveness and
efficiency of health services [28]. However, uptake and
use of new technologies can be slow, even when clinical
effectiveness is already known [14, 29]. NPT provides a
useful sensitising theory to inform analysis of implemen-
tation, identifying coherence—the mechanism by which
participants understand an innovation and its purpo-
se—as one of four essential components to the work of
bringing an innovation into routine practice. Informed
by this, we explored attitudes of general practice staff
before they began to pilot the Prism tool. We were inter-
ested to know how respondents understood what Prism
was and what it was for.
NPT suggests that achieving the embedding of innovation
into routine use is dependent on coherence [21], yet previ-
ous applications of the theory have identified that achieving
coherence can be the most common obstacle to implemen-
tation [30–32].
We found that, in terms of the four tasks which May
and Finch [21] suggested make up coherence, there was
a mixed story from our respondents. There seemed to
be clear agreement on what the tool was—a techno-
logical formalisation of existing practice—and a common
understanding that it would function as a support to
clinical judgment, rather than a replacement for it. Re-
spondents generally saw Prism as something additional
to their existing workload, rather than at the core of it.
Though Prism stratifies the whole patient population, re-
spondents tended to focus in their discussion on those
at the highest risk. When it came to agreeing a purpose,
there was broad consensus about the role Prism might
have in delivering new models of care based on active
management of patients, but also some scepticism. Scep-
ticism about the potential impact of Prism went along
two contradictory lines: one was that it would not be
useful in identifying high-risk patients, because these
were already known; the other was that it would uncover
previously unknown high risk patients for whom no
practical support could be delivered.
In terms of the work needed to put Prism into use, the
majority of respondents did not anticipate that gathering
information from the tool would be a major task in it-
self. The anticipated workload came with what follo-
wed—since the tool has no scope to make an impact in
isolation, it would lead to a new workload in terms of
reviewing patient needs, care planning, and identifying
and setting up support services. There was some anxiety
about inappropriately raised expectations, and, to a small
extent, liability for responding to identified needs. These
concerns spilled over into the consideration of the po-
tential value of Prism—because respondents were well
aware of the constrained supply of community based
care, which would limit the scope for delivering care to
patients identified through using Prism, and created un-
certainty in what Prism could achieve. One respondent’s
comment about the ‘Golden Goose’ referenced, deliber-
ately or not, the world of fairytales.1 Our findings seem
to concur with previous work on case management
models—which include identification of patients at risk
as one of their core tasks—which has found impact to
be limited for many reasons, including difficulty of en-
gaging with GPs [33].
Although we focussed on the NPT component of co-
herence, there were clear references to other compo-
nents of the theory—for example, the comments about
respondents’ plans to use the tool in clinical meetings
relates to the NPT component of collective action. The
potential for overlap between constructs, and the influ-
ence they can have on each other in the dynamic process
of implementation, has previously been noted [22]; we
intend to return to the story of Prism implementation to
see how the four constructs have played out over time.
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What was striking was, on balance, how the pressures
of a rising numbers of patients with long term condi-
tions, together with national, regional and local policy
drivers to anticipate patient needs and reducing demand
for unscheduled and emergency care, meant that they
were open to trying out Prism as it offered at least a
hope of improvement. Open-minded willingness to try
the tool seemed to over-ride the scepticism, anxiety and
uncertainty. A stronger and clearer message to practi-
tioners about the potential benefits of the tool would
have been a useful support, but the challenge to offering
this was the absence of evidence—which is what the
PRISMATIC trial itself was designed to produce.
During the course of the fieldwork, changes to the GP
contract introduced new rewards for identifying high
risk patients, and Prism was well placed to support prac-
tices’ response to this. However, what was encouraged
by the new payment scheme was identification of pa-
tients at highest risk of emergency admission, and inter-
ventions for only a small proportion of these. This was a
very narrow focus compared with the much wider range
of functions and possibilities available through Prism,
and one which is at odds with a literature which sug-
gests that the biggest scope for impact is in identifying
and working with the groups of patients in the risk band
below the very top, whose needs may be less immediate
or extreme [34].
Strengths and limitations of the study
We interviewed 43 primary care staff with a wide range
of experiences, from 32 general practices across rural
and urban, prosperous and deprived communities. The
data provide a comprehensive spread of views in terms
of practices and roles represented. However, in most
cases we talked to only one person from each practice
and so were not able to explore in full the extent to
which those people’s views were representative of their
colleagues, nor to discuss in any depth the relative
merits of using the tool in an individual or group setting.
It may be that there were wide ranges in attitude and ex-
pectations among colleagues within a single practice.
These practices had volunteered to take part in the
PRISMATIC trial, committing themselves to using the
tool for a fixed time period, and receiving a small pay-
ment to acknowledge the additional demands on time of
practice staff associated with participation in the study.
Their views may not be typical of doctors and other staff
in practices which did not opt to take part in the study.
This paper examines coherence among the potential
front-line users. Their views may differ from those of
local commissioners and managers with responsibility
for services required by patients at risk of emergency ad-
mission and likely to be identified by the technology.
During the course of our fieldwork, practices were in-
formed that a new payment would be available for iden-
tifying and managing patients at high risk of hospital
admission. In those interviews which took place after
this announcement, responses would have been in-
formed and potentially influenced by awareness of this
payment and the potential role of Prism in earning it,
while in the focus groups and interviews before the an-
nouncement, respondents would not necessarily have
known that such a payment innovation was planned.
Conclusions
NPT provided a useful framework to help us to examine
attitudes of practice staff to a predictive risk tool at the
point of its introduction. We know that stages of adop-
tion and implementation are part of a process that com-
prises both formal organisational decisions and informal
decisions by individual users [35]. Overall, respondents’
views were not a coherent story but a mix of open-
minded willingness, scepticism, anxiety and uncertainty.
This mix of views was observed within individual GPs’,
nurses’ and practice managers’ responses, as well as be-
ing reflected in a range of viewpoints from different in-
dividuals. The fact that Prism was offered to practices as
part of a trial meant that it could be perceived as a low
risk, ‘no obligation’ option. The small scale incentives
which came with participation in the Prismatic trial were
simply for taking part, and did not depend on success-
fully identifying new patients or delivering interventions
to them. Taking the first step of agreeing to take part in
the trial and installing Prism in the practice required a
relatively small investment of time and effort, and—un-
like the use of many other risk prediction tools—no cost.
Further research will explore how expectations at the
pre-adoption stage compare to decisions and actual use
of the technology in general practice. Our PRISMATIC
study will follow up general practice staff over 18 months
to explore whether and how they use the new technol-
ogy, allowing us to consider the other mechanisms iden-
tified in NPT.
Endnotes
1Grimm’s Fairy Tales contain two stories about geese
and gold: the goose who lays the golden eggs is the
source of undreamt of bounty; but another story has a
golden goose to which the unwary stick when they grab
it, with unfortunate consequences. We assume that our
respondent was thinking of the former.
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